Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Mohamed Attauabi; Jakob Seidelin; Johan Burisch; Danish COVID-IBD Study Group; Malte  Rosager Hansen; Pia Susanne Munkholm

doi:10.1136/gutjnl-2021-324397

Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Mohamed Attauabi, Jakob Seidelin, Johan Burisch, Danish COVID-IBD Study Group, Malte Rosager Hansen (Member of author group), Pia Susanne Munkholm (Member of author group)

14 Citations (Scopus)

Original language	English
Article number	gutjnl-2021-324397
Journal	Gut
Volume	70
Issue number	10
Pages (from-to)	2020-2022
Number of pages	3
ISSN	0017-5749
DOIs	https://doi.org/10.1136/gutjnl-2021-324397
Publication status	Published - Oct 2021

Keywords

5-aminosalicylic acid (5-ASA)
COVID-19
crohn's disease
inflammatory bowel disease
ulcerative colitis

Access to Document

10.1136/gutjnl-2021-324397

Cite this

@article{89328d64e8d14edd8c0719da60360b65,

title = "Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?",

keywords = "5-aminosalicylic acid (5-ASA), COVID-19, crohn's disease, inflammatory bowel disease, ulcerative colitis",

author = "Mohamed Attauabi and Jakob Seidelin and Johan Burisch and \{Danish COVID-IBD Study Group\} and \{Rosager Hansen\}, Malte and Munkholm, \{Pia Susanne\}",

year = "2021",

month = oct,

doi = "10.1136/gutjnl-2021-324397",

language = "English",

volume = "70",

pages = "2020--2022",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "10",

}

TY - JOUR

T1 - Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19

T2 - an artefactual result of research methodology?

AU - Attauabi, Mohamed

AU - Seidelin, Jakob

AU - Burisch, Johan

AU - Danish COVID-IBD Study Group

A2 - Rosager Hansen, Malte

A2 - Munkholm, Pia Susanne

PY - 2021/10

Y1 - 2021/10

KW - 5-aminosalicylic acid (5-ASA)

KW - COVID-19

KW - crohn's disease

KW - inflammatory bowel disease

KW - ulcerative colitis

UR - https://www.scopus.com/pages/publications/85101970874

U2 - 10.1136/gutjnl-2021-324397

DO - 10.1136/gutjnl-2021-324397

M3 - Letter

C2 - 33658323

SN - 0017-5749

VL - 70

SP - 2020

EP - 2022

JO - Gut

JF - Gut

IS - 10

M1 - gutjnl-2021-324397

ER -

Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

Keywords

Access to Document

Other files and links

Cite this